The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX‐47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues

Publisher Website
Google Scholar
Abstract
The high‐frequency blood group antigen Oka is carried on a red cell membrane glycoprotein (gp) of 35–69 kDa that is widely distributed on malignant cells of different origins. Immunostaining of hemopoietic cells and a range of normal human tissues demonstrated a wide distribution of the Oka gp that appears to be nonlineage‐restricted, although certain tissues show differentiation‐related expression. Oka gp was purified from red cell membranes by immunoaffinity chromatography using mAb A103 and amino acid sequence analysis was performed. The N‐terminal 30 amino acids are identical to the predicted sequence of M6 leukocyte activation antigen (M6), a member of the Ig superfamily (IgSF) with two IgSF domains. There are homologs in rat (MRC OX‐47 or CE9), in mouse (basigin or gp42), and in chicken (HT7 or neurothelin). The molecular basis of the Oka mutation was established by sequencing M6 cDNA derived from normal and Ok(a‐) EBV‐transformed B cell lines. A point mutation in the translated portion of M6 cDNA, G331 AG → AAG gives rise to a predicted E92 → K amino acid change in the first Ig‐like domain of the Ok(a‐) form of the protein. Transfection of mouse NS‐0 cells with normal or Ok(a‐) cDNA confirmed the identity of the protein and only the Ok(a‐) transfectants failed to react with monoclonal anti‐Oka Ab.

This publication has 35 references indexed in Scilit: